Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：200901004586233894
Update date: Dec. 18, 2024 Taguchi Kyoji
タグチ キョウジ | Taguchi Kyoji
Clips
Showa Pharmaceutical University Faculty of Pharmaceutical Sciences, Department of Bio-Pharmacy
About Showa Pharmaceutical University Faculty of Pharmaceutical Sciences, Department of Bio-Pharmacy
MISC (39)：
- K Ishiwata, Y Koyanagi, K Abe, K Kawamura, K Taguchi, T Saitoh, J Toda, T Sano. No reduction of dopamine transporter binding sites in mice following treatment with the TIQ analogue 1-benzyl-1,2,3,4-tetrahydroisoquinoline. BRAIN RESEARCH. 2003. 960. 1-2. 282-285
- K Abe, K Ishida, M Kato, T Shigenaga, K Taguchi, T Miyatake. Effect of morphine-induced antinociception is altered by AF64A-induced lesions on cholinergic neurons in rat nucleus raphe magnus. ACTA PHARMACOLOGICA SINICA. 2002. 23. 11. 961-966
- T Chuma, K Taguchi, M Kato, K Abe, Utsunomiya, I, K Miyamoto, T Miyatake. Modulation of noradrenergic and serotonergic transmission by noxious stimuli and intrathecal morphine differs in the dorsal raphe nucleus of anesthetized rat: in vivo voltammetric studies. NEUROSCIENCE RESEARCH. 2002. 44. 1. 37-44
- Stereoselective effect of (R)-and(S)-1-methyl-1,2,3,4-tetrahydroisoquinoline-induced parkinson's disease. Brain Research Bulletin. 2001. 56, 55-60
- Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydrexyisoquinolines on a mouse model of Parkinsonism in the mouse. Brain Research. 2001. 907, 134-138
- (BLANK)
- (BLANK)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
